Barclays
SHACW

Barclays’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

Barclays’s Portfolio SHACW Stock Details SHACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,500
Closed – – 5542
2022
Q3 		$0 Hold
2,500
– – ﹤0.01% 5299
2022
Q2 		$0 Hold
2,500
– – ﹤0.01% 5442
2022
Q1 		$0 Buy
+2,500
New +$964 ﹤0.01% 5797

Barclays's SHACW Position: Q4 2022 in Review

Barclays sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 2,500 shares.

Barclays first reported a position in SHACW in Q1 2022 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

  • Barclays reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
  • Barclays sold 2,500 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022.
  • Barclays first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q1 2022 and held it in 3 quarters.
  • Barclays's SCP & CO Healthcare Acquisition Company Warrant position peaked at $0 in Q3 2022.
  • 0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.